Neil Herskowitz Biography and Net Worth

Director of Avenue Therapeutics

Mr. Herskowitz joined our Board of Directors in December 2015. Mr. Herskowitz has served as the managing member of the ReGen Group of companies, located in New York, since 1998, which include ReGen Capital Investments LLC and Riverside Claims Investments LLC. He has also served as the President of its affiliate, Riverside Claims LLC, since June 2004.  He also serves as Chairman of the board of directors of Starting Point Services for Children, a not-for-profit corporation. Mr. Herskowitz received a B.B.A. in Finance from Bernard M. Baruch College in 1978.

How do I contact Neil Herskowitz?

The corporate mailing address for Mr. Herskowitz and other Avenue Therapeutics executives is 1140 Avenue of the Americas Floor 9, NEW YORK NY, 10036. Avenue Therapeutics can also be reached via phone at (781) 652-4500 and via email at [email protected] Learn More on Neil Herskowitz's contact information.

Has Neil Herskowitz been buying or selling shares of Avenue Therapeutics?

Neil Herskowitz has not been actively trading shares of Avenue Therapeutics during the last quarter. Most recently, on Thursday, May 6th, Neil Herskowitz bought 2,500 shares of Avenue Therapeutics stock. The stock was acquired at an average cost of $3.99 per share, with a total value of $9,975.00. Learn More on Neil Herskowitz's trading history.

Who are Avenue Therapeutics' active insiders?

Avenue Therapeutics' insider roster includes Neil Herskowitz (Director), and Joseph Vazzano (CFO). Learn More on Avenue Therapeutics' active insiders.

Neil Herskowitz Insider Trading History at Avenue Therapeutics

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/6/2021Buy2,500$3.99$9,975.00View SEC Filing Icon  
5/6/2021Buy2,500$3.99$9,975.00View SEC Filing Icon  
2/27/2020Buy2,400$8.20$19,680.00View SEC Filing Icon  
2/25/2020Buy10,000$8.98$89,800.00View SEC Filing Icon  
6/18/2019Buy5,000$5.86$29,300.00View SEC Filing Icon  
4/15/2019Buy1,000$4.52$4,520.00View SEC Filing Icon  
3/28/2019Buy600$5.11$3,066.00View SEC Filing Icon  
2/25/2019Buy5,000$5.46$27,300.00View SEC Filing Icon  
2/5/2019Buy8,850$5.88$52,038.00View SEC Filing Icon  
1/30/2019Buy650$5.91$3,841.50View SEC Filing Icon  
1/28/2019Buy1,447$5.84$8,450.48View SEC Filing Icon  
4/25/2018Buy1,000$3.80$3,800.00View SEC Filing Icon  
10/17/2017Buy1,000$5.01$5,010.00View SEC Filing Icon  
10/9/2017Buy500$5.24$2,620.00View SEC Filing Icon  
See Full Table

Neil Herskowitz Buying and Selling Activity at Avenue Therapeutics

This chart shows Neil Herskowitz's buying and selling at Avenue Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Avenue Therapeutics Company Overview

Avenue Therapeutics logo
Avenue Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes products primarily for use in the acute/intensive care hospital setting. Its product candidate is intravenous Tramadol, a synthetic dual-acting opioid, which is in Phase III clinical trials for the treatment of post-operative acute pain. The company was incorporated in 2015 and is based in New York, New York.
Read More

Today's Range

Now: $4.50
Low: $3.62
High: $6.35

50 Day Range

MA: $5.29
Low: $3.21
High: $67.50

2 Week Range

Now: $4.50
Low: $3.00
High: $27.75


5,738,600 shs

Average Volume

202,834 shs

Market Capitalization

$98.95 million

P/E Ratio


Dividend Yield